Business Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal admin December 22, 2023 Bristol Myers Squibb said it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash. Continue Reading Previous Previous post: Nike, Foot Locker shares plunge after sneaker maker cuts revenue outlookNext Next post: Here’s when you can visit a national park for free in 2024 Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Related News Star Wars was the first Lego license — 25 years later, it’s stronger than ever May 4, 2024 Dave & Buster’s plan to allow betting on arcade games draws scrutiny May 3, 2024
